News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Venture Capitalists Say Investing in a Medical Device Start-Up Has Gotten Riskier, According to Silicon Valley Bank Study


5/20/2011 8:00:34 AM

Investing in a medical device company these days does not come cheap. Venture capitalists said at a panel during Thursday’s MedTech Investing Conference in Minneapolis that the cost and risk of bringing medical device start-ups to market has gotten so expensive, it has caused at least one of them to change their business model. Jan Garfinkle, managing director of Ann Arbor-based Arboretum Ventures, said her venture capital firm used to be 75 percent focused on medical devices and diagnostics. She estimates that will be modified to 60 percent, with the remaining going toward healthcare services and life science tools.

Read at Star Tribune

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES